Renovorx (RNXT) traded up 1.55 % during a 24 hours period ending at 12:58 PM Central Europe on Tuesday 27th. One Renovorx stock can currently be bought for about USD 1.31 on popular exchanges. Current supply of Renovorx stocks is 45 mn. Renovorx has a current market capitalization of USD 58.2 mn and approximately USD 238.2 k worth of Renovorx was traded on exchanges in the last 24 hours. Since last month end, Renovorx has traded -15.48 % down. Simple moving average of last 200 days is at USD 1.1. The highest price of past 52 weeks was recorded at USD 2.59 on 09/02/2026. 52 weeks low was at USD 0.7 on 11/14/2025.
Here is how related stocks have performed in the past 24 hours:
Broadwind (BWEN) traded up 3.45 % and now trades at USD 3. Broadwind has a market capitalisation of USD 68.9 mn. Current price/earnings ratio for Broadwind is 8.31.
Air T Funding (AIRTP) traded down -0.19 % and now trades at USD 18.71. Current market capitalisation for Air T Funding is USD 69.5 mn. Current price/earnings ratio for Air T Funding is 1.25.
Rank One Computing (ROC) traded down -4.7 % and now trades at USD 3.45. Current market capitalisation for Rank One Computing is USD 69.1 mn.
Cardiff Oncology (CRDF) traded down -12.09 % and now trades at USD 0.8. Cardiff Oncology has a market capitalisation of USD 69.6 mn.
Cognition Therapeutics (CGTX) traded down -3.34 % and now trades at USD 0.69. Cognition Therapeutics has a market capitalisation of USD 68.4 mn.
About Renovorx
RenovoRx, Inc. is a clinical-stage biopharmaceutical company based in Los Altos, California, USA. The company specializes in developing therapies for the local treatment of solid tumors and targeted chemotherapy delivery for pancreatic cancer patients.